Literature DB >> 26474804

Finding new drugs to enhance anion secretion in cystic fibrosis: Toward suitable systems for better drug screening. Report on the pre-conference meeting to the 12th ECFS Basic Science Conference, Albufeira, 25-28 March 2015.

Alan S Verkman1, Aleksander Edelman2, Margarida Amaral3, Marcus A Mall4, Jeffrey M Beekman5, Torsten Meiners6, Luis J V Galietta7, Christine E Bear8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26474804      PMCID： PMC4786369          DOI： 10.1016/j.jcf.2015.10.001

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN： 1569-1993            Impact factor:   5.482


× No keyword cloud information.
  56 in total

Review 1.  Biosynthesis of cystic fibrosis transmembrane conductance regulator.

Authors:  Iwona M Pranke; Isabelle Sermet-Gaudelus
Journal:  Int J Biochem Cell Biol       Date:  2014-03-28       Impact factor: 5.085

Review 2.  High-throughput fluorescence microscopy for systems biology.

Authors:  Rainer Pepperkok; Jan Ellenberg
Journal:  Nat Rev Mol Cell Biol       Date:  2006-07-19       Impact factor: 94.444

Review 3.  Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications.

Authors:  Toshiro Sato; Hans Clevers
Journal:  Science       Date:  2013-06-07       Impact factor: 47.728

4.  Cyanoquinolines with independent corrector and potentiator activities restore ΔPhe508-cystic fibrosis transmembrane conductance regulator chloride channel function in cystic fibrosis.

Authors:  Puay-Wah Phuan; Baoxue Yang; John M Knapp; Alex B Wood; Gergely L Lukacs; Mark J Kurth; A S Verkman
Journal:  Mol Pharmacol       Date:  2011-07-05       Impact factor: 4.436

5.  Microfluidics platform for measurement of volume changes in immobilized intestinal enteroids.

Authors:  Byung-Ju Jin; Sailaja Battula; Nick Zachos; Olga Kovbasnjuk; Jennifer Fawlke-Abel; Julie In; Mark Donowitz; Alan S Verkman
Journal:  Biomicrofluidics       Date:  2014-04-01       Impact factor: 2.800

6.  Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

Authors:  Claire E Wainwright; J Stuart Elborn; Bonnie W Ramsey; Gautham Marigowda; Xiaohong Huang; Marco Cipolli; Carla Colombo; Jane C Davies; Kris De Boeck; Patrick A Flume; Michael W Konstan; Susanna A McColley; Karen McCoy; Edward F McKone; Anne Munck; Felix Ratjen; Steven M Rowe; David Waltz; Michael P Boyle
Journal:  N Engl J Med       Date:  2015-05-17       Impact factor: 91.245

7.  Synergy-based small-molecule screen using a human lung epithelial cell line yields ΔF508-CFTR correctors that augment VX-809 maximal efficacy.

Authors:  Puay-Wah Phuan; Guido Veit; Joseph Tan; Ariel Roldan; Walter E Finkbeiner; Gergely L Lukacs; A S Verkman
Journal:  Mol Pharmacol       Date:  2014-04-15       Impact factor: 4.436

8.  Mechanism-based corrector combination restores ΔF508-CFTR folding and function.

Authors:  Tsukasa Okiyoneda; Guido Veit; Johanna F Dekkers; Miklos Bagdany; Naoto Soya; Haijin Xu; Ariel Roldan; Alan S Verkman; Mark Kurth; Agnes Simon; Tamas Hegedus; Jeffrey M Beekman; Gergely L Lukacs
Journal:  Nat Chem Biol       Date:  2013-05-12       Impact factor: 15.040

9.  Expression cloning of TMEM16A as a calcium-activated chloride channel subunit.

Authors:  Björn Christian Schroeder; Tong Cheng; Yuh Nung Jan; Lily Yeh Jan
Journal:  Cell       Date:  2008-09-19       Impact factor: 41.582

Review 10.  Targeting ion channels in cystic fibrosis.

Authors:  Marcus A Mall; Luis J V Galietta
Journal:  J Cyst Fibros       Date:  2015-06-23       Impact factor: 5.482
View more
  1 in total

Review 1.  Impact of gene editing on the study of cystic fibrosis.

Authors:  Patrick T Harrison; David J Sanz; Jennifer A Hollywood
Journal:  Hum Genet       Date:  2016-06-21       Impact factor: 4.132
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.